Publication year: 2021
: 1119564654
Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists
: Chemistry, Pharmaceutical & Medicinal Chemistry, Biopharmaceuticals, Pharmaceutical Biotechnology, Biologicals, Pharmacokinetics, Biological products